Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

S. Loi; S. Michiels; R. Salgado; N. Sirtaine; V. Jose; D. Fumagalli; P-L Kellokumpu-Lehtinen; P. Bono; V. Kataja; C. Desmedt; M. J. Piccart; S. Loibl; C. Denkert; M. J. Smyth; H. Joensuu; C. Sotiriou

doi:10.1093/annonc/mdu112

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

S. Loi, S. Michiels, R. Salgado, N. Sirtaine, V. Jose, D. Fumagalli, P-L Kellokumpu-Lehtinen, P. Bono, V. Kataja, C. Desmedt, M. J. Piccart, S. Loibl, C. Denkert, M. J. Smyth, H. Joensuu, C. Sotiriou

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Lehti	Annals of Oncology
Vuosikerta	25
Numero	8
Sivut	1544-1550
Sivumäärä	7
ISSN	0923-7534
DOI - pysyväislinkit	https://doi.org/10.1093/annonc/mdu112
Tila	Julkaistu - elokuuta 2014
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3122 Syöpätaudit

Pääsy asiakirjaan

10.1093/annonc/mdu112

Siteeraa tätä

Loi, S., Michiels, S., Salgado, R., Sirtaine, N., Jose, V., Fumagalli, D., Kellokumpu-Lehtinen, P-L., Bono, P., Kataja, V., Desmedt, C., Piccart, M. J., Loibl, S., Denkert, C., Smyth, M. J., Joensuu, H., & Sotiriou, C. (2014). Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. Annals of Oncology, 25(8), 1544-1550. https://doi.org/10.1093/annonc/mdu112

Loi, S. ; Michiels, S. ; Salgado, R. ; Sirtaine, N. ; Jose, V. ; Fumagalli, D. ; Kellokumpu-Lehtinen, P-L ; Bono, P. ; Kataja, V. ; Desmedt, C. ; Piccart, M. J. ; Loibl, S. ; Denkert, C. ; Smyth, M. J. ; Joensuu, H. ; Sotiriou, C. / Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer : results from the FinHER trial. Julkaisussa: Annals of Oncology. 2014 ; Vuosikerta 25, Nro 8. Sivut 1544-1550.

@article{9c9b5c2daa9744c3bc439560391c6c12,

title = "Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial",

keywords = "lymphocytic infiltration, breast cancer, prognosis, prediction, biomarkers trastuzumab efficacy, TILs, GASTROINTESTINAL STROMAL TUMOR, ADAPTIVE IMMUNITY, PLUS DOCETAXEL, CHEMOTHERAPY, RESISTANCE, IMATINIB, THERAPY, REPERTOIRE, INHIBITION, EXPRESSION, 3122 Cancers",

author = "S. Loi and S. Michiels and R. Salgado and N. Sirtaine and V. Jose and D. Fumagalli and P-L Kellokumpu-Lehtinen and P. Bono and V. Kataja and C. Desmedt and Piccart, {M. J.} and S. Loibl and C. Denkert and Smyth, {M. J.} and H. Joensuu and C. Sotiriou",

year = "2014",

month = aug,

doi = "10.1093/annonc/mdu112",

language = "English",

volume = "25",

pages = "1544--1550",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "8",

}

Loi, S, Michiels, S, Salgado, R, Sirtaine, N, Jose, V, Fumagalli, D, Kellokumpu-Lehtinen, P-L, Bono, P, Kataja, V, Desmedt, C, Piccart, MJ, Loibl, S, Denkert, C, Smyth, MJ, Joensuu, H & Sotiriou, C 2014, 'Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial', Annals of Oncology, Vuosikerta 25, Nro 8, Sivut 1544-1550. https://doi.org/10.1093/annonc/mdu112

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer : results from the FinHER trial. / Loi, S.; Michiels, S.; Salgado, R.; Sirtaine, N.; Jose, V.; Fumagalli, D.; Kellokumpu-Lehtinen, P-L; Bono, P.; Kataja, V.; Desmedt, C.; Piccart, M. J.; Loibl, S.; Denkert, C.; Smyth, M. J.; Joensuu, H.; Sotiriou, C.

julkaisussa: Annals of Oncology, Vuosikerta 25, Nro 8, 08.2014, s. 1544-1550.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer

T2 - results from the FinHER trial

AU - Loi, S.

AU - Michiels, S.

AU - Salgado, R.

AU - Sirtaine, N.

AU - Jose, V.

AU - Fumagalli, D.

AU - Kellokumpu-Lehtinen, P-L

AU - Bono, P.

AU - Kataja, V.

AU - Desmedt, C.

AU - Piccart, M. J.

AU - Loibl, S.

AU - Denkert, C.

AU - Smyth, M. J.

AU - Joensuu, H.

AU - Sotiriou, C.

PY - 2014/8

Y1 - 2014/8

KW - lymphocytic infiltration

KW - breast cancer

KW - prognosis

KW - prediction

KW - biomarkers trastuzumab efficacy

KW - TILs

KW - GASTROINTESTINAL STROMAL TUMOR

KW - ADAPTIVE IMMUNITY

KW - PLUS DOCETAXEL

KW - CHEMOTHERAPY

KW - RESISTANCE

KW - IMATINIB

KW - THERAPY

KW - REPERTOIRE

KW - INHIBITION

KW - EXPRESSION

KW - 3122 Cancers

U2 - 10.1093/annonc/mdu112

DO - 10.1093/annonc/mdu112

M3 - Article

VL - 25

SP - 1544

EP - 1550

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 8

ER -